Aadi Bioscience Inc (AADI)
1.98
-0.14
(-6.60%)
USD |
NASDAQ |
May 06, 16:00
1.98
0.00 (0.00%)
After-Hours: 17:41
Aadi Bioscience Profit Margin (Quarterly): -257.2% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -257.2% |
| September 30, 2023 | -273.6% |
| June 30, 2023 | -289.8% |
| March 31, 2023 | -259.5% |
| December 31, 2022 | -266.2% |
| September 30, 2022 | -341.0% |
| June 30, 2022 | -531.5% |
| Date | Value |
|---|---|
| March 31, 2022 | -600.7% |
| December 31, 2021 | -1.60K% |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | 57.29% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-1.60K%
Minimum
Dec 2021
57.29%
Maximum
Dec 2020
-436.1%
Average
-281.7%
Median
Profit Margin (Quarterly) Benchmarks
| Aquestive Therapeutics Inc | -61.42% |
| 89bio Inc | -- |
| NovaBay Pharmaceuticals Inc | -110.2% |
| Palatin Technologies Inc | -385.6% |
| iBio Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -49.88% |
| Return on Assets | -42.25% |
| Return on Invested Capital | -49.88% |
| Gross Profit Margin (Quarterly) | 85.35% |
| Operating Margin (Quarterly) | -280.0% |
| Return on Net Operating Assets | -527.4% |